Recent advancement of piperidine moiety in treatment of cancer- A review

Eur J Med Chem. 2018 Sep 5:157:480-502. doi: 10.1016/j.ejmech.2018.08.017. Epub 2018 Aug 8.

Abstract

Piperidine is an important pharmacophore, a privileged scaffold and an excellent heterocyclic system in the field of drug discovery which provides numerous opportunities in studying/exploring this moiety as an anticancer agent by acting on various receptors of utmost importance. Cancer is an uncontrolled division of cells that results in the formation of tumour which have the potential to migrate to other parts of the body (metastasis) finally becoming a major threat to human population. Since piperidine displayed great potential in this area it is being further probed to get novel entities for the treatment of cancer. This review throws light on recent biological expansions of piperidine along with structure activity relationships to deliver association between various synthesized newer/novel derivatives and receptor sites.

Keywords: Anticancer; Piperidine; SAR.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Matrix Metalloproteinase Inhibitors / chemistry
  • Matrix Metalloproteinase Inhibitors / pharmacology*
  • Matrix Metalloproteinases / metabolism*
  • Molecular Structure
  • Neoplasms / drug therapy*
  • Piperidines / chemistry
  • Piperidines / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Matrix Metalloproteinase Inhibitors
  • Piperidines
  • piperidine
  • Matrix Metalloproteinases